knowledge -WSS

knowledge

author：comprehensive 2025-09-29 23:28:03 - browse：8183

A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ rate of cognitive and functional decline by 35% compared to placebo, the company said Wednesday, paving the way for a submission to the Food and Drug Administration and boosting hopes for a new class of Alzheimer’s drugs.

But the positive outcome of the study involving the drug, called donanemab, could be tempered by the deaths of two patients, and possibly a third, from a type of brain swelling caused by these drugs.

The results of the study were reported in a press release and have not yet been reviewed by outside scientists. Lilly said the data will be used to file for full approval with the FDA before the end of June. If cleared, donanemab will compete with another new Alzheimer’s treatment, Leqembi, made by Eisai and Biogen, that secured FDA approval in January.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Rise in cancer among younger people worries and puzzles doctors

WSS

UHS says company favors patients whose insurance pays more

Ask STAT: What do you want to know about ChatGPT in medicine?

Disclosing genetic information: not as worrisome as once feared

STAT Report: Patient voices and perspectives

The battle over the Brookhaven Landfill on Long Island

STAT's guide to the next generation of CAR

focus

knowledge

focus

Trump demands the U.S. pay no more for drugs than other countries … again

WATCH: Why do fingernails fall off when they're damaged?

Continuity nursing helped my family in our darkest PICU moments

The story of mRNA: From a loose idea to a tool that may help curb Covid

The cancer drug shortage isn’t new — and neither are the solutions

The story of mRNA: From a loose idea to a tool that may help curb Covid

Medical records are filled with copy

UHS says company favors patients whose insurance pays more

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Truvian presents data for its desktop blood

explore

'Investigate these claims': UFO transparency at center of House hearing

In the gardens at Boston Children's Hospital, families find sanctuary

'Investigate these claims': UFO transparency at center of House hearing

STAT's guide to the next generation of CAR

Former reverend arrested for allegedly killing 8

Why are elite athletes different? Take a look at their microbes

leisure time

knowledge

leisure time

leisure time